- 询价
- 辰辉创聚生物
- 中国
- NBL-240387
- 2025年07月08日
企业认证
相关产品推荐更多 >
CD146/MCAM抗体 | Recombinant Anti-CD146/MCAM Monoclonal Antibody
询价
cIAP2/BIRC3抗体 | Anti-cIAP2/BIRC3 Polyclonal Antibody
询价
抗Monkeypox virus/MPXV M1R Nanobody | Anti-Monkeypox virus/MPXV M1R Nanobody
询价
山羊抗牛血清白蛋白抗体 | Goat Anti-BSA Polyclonal Antibody
询价
Adiponectin Receptor 2 Polyclonal Antibody抗体 | Anti-Adiponectin Receptor 2 Polyclonal Antibody
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
丙型肝炎病毒NS5抗原 Hepatitis C virus NS5 antigen
- 形态：
liquid
- 保存条件：
-20°C
- 克隆性：
单克隆
- 保质期：
见 COA
- 供应商：
辰辉创聚生物
- 浓度：
0.50 mg/ml
- 抗体英文名：
Hepatitis C virus NS5 antigen Antibody
- 抗体名：
抗丙型肝炎病毒NS5抗原
- 规格：
100µg
品名：NebuSelect™ Anti-Hepatitis C virus NS5 antigen Monoclonal Antibody
货号：NBL-240387
规格：100µg
产品描述：This antibody is recognizing the NS5 antigen (Clone 2F6/G11) spanning N2054-C2295 of the HCV (subtype 1a) sequence. It has been produced using highly purified NS-5 antigen.
应用：This antibody is reactive in ELISA and dot blot tests. IgG Subtype: IgG-1.
别名：丙型肝炎病毒NS5抗原抗体,Hepatitis C virus NS5 antigen抗体,Hepatitis C virus NS5 antigen Antibody
溶解度：Solution in 0.50 mg/ml in 0.1M Tris-HCl (pH 7.5)
储存条件：-20°C
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification and Crystallization of NS5A Domain I of Hepatitis C Virus
The NS5A protein of HCV is an essential component of the viral RNA replication machinery and may also function in modulation of the host cell environment. The exact function of NS5A in these processes remains unknown. NS5A is a large
Genotyping Hepatitis C Virus by Type-Specific Primers for PCR Based on NS5 Region
Hepatitis C virus (HCV), a flavi-like virus with a positive-sense, single-stranded genome RNA (1 –3 ), shows considerable variation in nucleotide sequences. These variations fall into a series of specific patterns and are the basis
Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B Polymerase)
The hepatitis C virus (HCV) chronically infects approx 4 million patients in the United States alone, and constitutes a major cause of chronic liver disease and hepatocellular carcinoma (1 –3 ). Current antiviral therapies for chronic
技术资料暂无技术资料 索取技术资料
